Literature DB >> 4031548

Vaginal redox potential in bacterial vaginosis (nonspecific vaginitis).

K K Holmes, K C Chen, C M Lipinski, D A Eschenbach.   

Abstract

To explore of the association of bacterial vaginosis with anaerobic bacterial growth in the vagina, we measured the redox potential (Eh) at the vaginal epithelial surface of women with this syndrome. Among normal women, the value for Eh in the vagina ranged from +322 mV to +137 mV (mean, +170 mV); whereas among women with bacterial vaginosis, the Eh ranged from +71 mV to as low as -257 mV (mean, -92 mV). Following successful treatment of the vaginosis with metronidazole, the vaginal Eh increased to a mean of +208 mV. Thus, the low redox potential in the vagina during bacterial vaginosis appears to be due to microbial metabolism in the vagina and does not represent a persistent host factor responsible for the anaerobic vaginal flora. Any host factors responsible for bacterial vaginosis remain to be elucidated.

Entities:  

Mesh:

Year:  1985        PMID: 4031548     DOI: 10.1093/infdis/152.2.379

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Defined medium simulating genital tract secretions for growth of vaginal microflora.

Authors:  A M Geshnizgani; A B Onderdonk
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 2.  Bacterial vaginosis.

Authors:  C A Spiegel
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study.

Authors:  Andrey Sgibnev; Elena Kremleva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-08       Impact factor: 3.267

Review 4.  Does the vaginal microbiota play a role in the development of cervical cancer?

Authors:  Maria Kyrgiou; Anita Mitra; Anna-Barbara Moscicki
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

5.  Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial.

Authors:  Taha E Taha; Newton I Kumwenda; George Kafulafula; Bonus Makanani; Chiwawa Nkhoma; Shu Chen; Amy Tsui; Donald R Hoover
Journal:  PLoS Clin Trials       Date:  2007-02-23

6.  Metabolic signatures of bacterial vaginosis.

Authors:  Sujatha Srinivasan; Martin T Morgan; Tina L Fiedler; Danijel Djukovic; Noah G Hoffman; Daniel Raftery; Jeanne M Marrazzo; David N Fredricks
Journal:  MBio       Date:  2015-04-14       Impact factor: 7.867

Review 7.  Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis.

Authors:  Muriel Aldunate; Daniela Srbinovski; Anna C Hearps; Catherine F Latham; Paul A Ramsland; Raffi Gugasyan; Richard A Cone; Gilda Tachedjian
Journal:  Front Physiol       Date:  2015-06-02       Impact factor: 4.566

8.  Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis.

Authors:  Jean M Macklaim; Andrew D Fernandes; Julia M Di Bella; Jo-Anne Hammond; Gregor Reid; Gregory B Gloor
Journal:  Microbiome       Date:  2013-04-12       Impact factor: 14.650

9.  Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation.

Authors:  Cecilia Noecker; Alexander Eng; Sujatha Srinivasan; Casey M Theriot; Vincent B Young; Janet K Jansson; David N Fredricks; Elhanan Borenstein
Journal:  mSystems       Date:  2016-01-19       Impact factor: 6.496

10.  Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis.

Authors:  J R Schwebke; M B Schulien; M Zajackowski
Journal:  Infect Dis Obstet Gynecol       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.